NOVONIX Statistics
Total Valuation
NOVONIX has a market cap or net worth of 174.58 million. The enterprise value is 204.39 million.
| Market Cap | 174.58M |
| Enterprise Value | 204.39M |
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.93% |
| Shares Change (QoQ) | +3.26% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 491.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 29.82 |
| PB Ratio | 1.27 |
| P/TBV Ratio | 1.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.73 |
| EV / Sales | 33.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.91 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.24 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.02 |
| Interest Coverage | -15.36 |
Financial Efficiency
Return on equity (ROE) is -46.54% and return on invested capital (ROIC) is -14.71%.
| Return on Equity (ROE) | -46.54% |
| Return on Assets (ROA) | -13.90% |
| Return on Invested Capital (ROIC) | -14.71% |
| Return on Capital Employed (ROCE) | -30.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.78 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.18% in the last 52 weeks. The beta is 1.21, so NOVONIX's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -46.18% |
| 50-Day Moving Average | 0.29 |
| 200-Day Moving Average | 0.40 |
| Relative Strength Index (RSI) | 52.40 |
| Average Volume (20 Days) | 93,197 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NOVONIX had revenue of 5.85 million and -74.82 million in losses. Loss per share was -0.15.
| Revenue | 5.85M |
| Gross Profit | 4.08M |
| Operating Income | -54.41M |
| Pretax Income | -74.72M |
| Net Income | -74.82M |
| EBITDA | -50.46M |
| EBIT | -54.41M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 42.56 million in cash and 71.45 million in debt, giving a net cash position of -28.90 million.
| Cash & Cash Equivalents | 42.56M |
| Total Debt | 71.45M |
| Net Cash | -28.90M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 137.59M |
| Book Value Per Share | 0.24 |
| Working Capital | 11.06M |
Cash Flow
In the last 12 months, operating cash flow was -40.42 million and capital expenditures -29.91 million, giving a free cash flow of -70.32 million.
| Operating Cash Flow | -40.42M |
| Capital Expenditures | -29.91M |
| Free Cash Flow | -70.32M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 69.76% |
| Operating Margin | -929.39% |
| Pretax Margin | -1,276.38% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NOVONIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.93% |
| Shareholder Yield | -1.93% |
| Earnings Yield | -42.86% |
| FCF Yield | -40.28% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NOVONIX has an Altman Z-Score of -0.68. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.68 |
| Piotroski F-Score | n/a |